Safe alongside your timeline
An evidence-based adjunctive therapy designed to work safely alongside conventional oncology, including chemotherapy and radiation, as an integrative protocol.
High-concentration intravenous nutrient therapy designed to support your body's resilience alongside conventional cancer care.

When vitamin C is taken orally, the digestive tract strictly limits how much can actually reach your cells. Delivering it intravenously bypasses those barriers, safely achieving blood levels that are impossible through oral supplementation alone.
At these elevated, clinical concentrations, vitamin C becomes a metabolic support tool for oncology care. It is thought to generate oxidative stress that is selectively toxic to cancer cells while sparing healthy ones, lower systemic inflammation, interfere with tumor blood vessel formation, and support immune function by increasing specific white blood cells.
An evidence-based adjunctive therapy designed to work safely alongside conventional oncology, including chemotherapy and radiation, as an integrative protocol.
Clinical research shows high-dose IVC is generally safe and well-tolerated, helping reduce deep fatigue, pain, nausea, and appetite loss during treatment.
Early research suggests IVC may benefit tumor response and survival when paired with standard treatment, particularly for advanced pancreatic, ovarian, and certain colorectal and lung cancers.
Starting early builds nutritional reserves and cellular resilience. Dosing is individualized, typically 1 to 3 times per week, with sessions lasting 1 to 3 hours.
To ensure your safety, specific laboratory investigations are mandatory before booking your first session.
Administration is built directly into your care journey at JOSIE. We handle all the booking and coordination logistics with our Toronto partner clinic for you. Let's look at your health data virtually, map out your needs, and seamlessly coordinate your in-person therapies.